Anti-SARS Cov-2 T Cell Infusions for COVID 19

PHASE1

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Due to trial's eligibility criteria and the low census of hospitalized COVID-19 patients meeting eligibility criteria, the Sponsor will be unable to enroll a meaningful number of patients in this single-center trial in a reasonable time frame.

Conditions

SARS-CoV 2
Viral Infection
COVID 19

Interventions

BIOLOGICAL: Dose Finding Phase (MTD)
BIOLOGICAL: Partially HLA-matched SARS-CoVSTs
OTHER: Routine care (no SARS-CoVSTs)

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]